MedTrace Logo

Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease

NCT01074580 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-01-26

No results posted yet for this study

Summary

The purpose of this study is investigate if high frequency sonography and contrast enhanced sonography can be used to predict remission in patients with deterioration of Crohn's disease treated with steroids or tumor necrosis factor (TNF) alfa inhibitors.

Conditions

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Trygve Hausken, PhD · Nastional Center of Gastroenterological Ultrasonography, Haukeland University Hospital, Bergen, Norway

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074580 on ClinicalTrials.gov